iron oxide Report issue

Small molecule Experimental
AACT Drug Central MeSH PubChem

Active Ingredient History

NOW
  • Now
Iron oxides are chemical compounds composed of iron and oxygen. Several iron oxides are recognized. Often they are non-stoichiometric. Oxyhydroxides are a related class of compounds, perhaps the best known of which is rust.   Wikipedia

Chemistry

More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: Missing data
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: Missing data

Alternative names

c.i. 77491 | colcothar | ferric iron oxide | ferric oxide | ferric oxide hydrate | ferric oxide monohydrate | ferric oxide red | gamma-ferric oxide | hematite | iron oxide | iron oxide, nanoparticles | lepidocrocite | maghemite | red iron oxide

Organizations (15)

Research & Development (15)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (12)

Approved Indications (1)


 

Iron Deficiencies

Experimental Indications - Clinical Trial Phases 1-4 (12)


 

Anemia, Iron-Deficiency (Phase 2)

Coronary Disease (Phase 1)

Diabetes Mellitus (Phase 1/Phase 2)

Iron Deficiencies (Early Phase 1)

Magnetic Resonance Imaging (Phase 2)

Melanosis (Phase 4)

Neoplasm Metastasis (Phase 3)

Pancreatic Neoplasms (Phase 4)

Prostatectomy (Phase 3)

Prostatic Neoplasms (Phase 3)

Renal Insufficiency, Chronic (Phase 1)

Stomach Neoplasms (Phase 1)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 13
  • # of Trial Organizations: 15

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue